Saudi Press

Saudi Arabia and the world
Tuesday, Jan 13, 2026

Stage 3 Lung Cancer Immunotherapy | Immunotherapy Drugs for Lung Cancer

Immunotherapy is a new form of cancer treatment, helping your body harness the power of your own immune system to manage stage 3 lung cancer.

Lung cancer is the most common cancer worldwide, causing 25% of all cancer deaths. That’s why researchers are working diligently to develop new treatment strategies to provide better outcomes for people living with advanced lung cancer.

If you’ve been diagnosed with stage 3 lung cancer, you likely have questions about your treatment options. Fortunately, there are many therapies your doctor may recommend to manage your condition. One of the newest methods of dealing with advanced lung cancers is immunotherapy, which harnesses the power of your body’s immune system to fight and kill cancer cells.

While immunotherapy shows promise as an effective treatment option for many people with stage 3 lung cancer, it’s not an appropriate treatment option for everyone. If you’re interested in immunotherapy, it’s best to ask your doctor if this treatment could be right for you.


Managing Stage 3 Lung Cancer


Lung cancer is categorized into two groups: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC makes up 80 to 85% of all diagnosed lung cancers. Regardless of the type, after a lung cancer diagnosis is made, doctors work quickly to determine the stage of the cancer—that is, whether or not the cancer has spread outside the lungs and, if so, how far.

People living with stage 3 lung cancer have tumors growing inside lung tissue as well as cancer that’s spread beyond the lungs. In general, stage 3 lung cancer affects the lungs and lymph nodes in the chest, including those surrounding the lungs and airways near the collarbone. While stage 3 lung cancer may affect lymph nodes on either side of the chest, it has not yet spread to distant organs or tissues.

For many people, advanced lung cancer is treated with a combination of therapies. Your treatment course depends on how far your cancer has spread and your overall health. Many people benefit from more traditional cancer therapies, including chemotherapy and radiation therapy. But while these are good options, they are not as precise as newer treatments like immunotherapy. Also, you may want to avoid some of the side effects of these classic treatment options. That’s where immunotherapy comes in.


Immunotherapy Explained

Immunotherapy is a relatively new form of treatment that uses your body’s own immune system to kill cancer cells. Immunotherapy drugs for lung cancer help your body better recognize and destroy cancer cells. But to understand how immunotherapy works, it’s important to first understand how your immune system works.

Your immune system sends fighter cells to attack invaders like bacteria and viruses. Typically, it knows to leave normal, healthy cells alone. This is accomplished by certain structures on immune system cells, called checkpoints, that get turned on or off depending on whether a cell is normal or not. Some cancer cells have the ability to fool your immune system to disregard the presence of abnormal, malignant cells.

Immunotherapy drugs target immune system cell checkpoints to encourage your body to attack harmful cancer cells. By stimulating these checkpoints, immunotherapy drugs effectively take the breaks off your immune system, releasing it to destroy cancer cells.

If immunotherapy is right for you, you’ll receive your medications as an intravenous (IV) infusion every two to three weeks. But keep in mind, like all cancer treatments, immunotherapy does pose the risk of certain side effects. You may experience fatigue, nausea, diarrhea, cough, skin rashes, or joint pain. In rare cases, immunotherapy drugs cause the immune system to attack other parts of your body, such as your liver or kidneys. If this occurs, your treatment may need to stop.

Immunotherapy is a newer form of treatment for stage 3 lung cancer, but it’s showing promise as an effective solution for dealing with this disease. While it isn’t right for everyone, immunotherapy may allow you to use your own body to help fight your cancer. If you’re interested in immunotherapy as a treatment option, ask your doctor whether this therapy could be right for you.

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Trump Designates Saudi Arabia a Major Non-NATO Ally, Elevating US–Riyadh Defense Partnership
Trump Organization Deepens Saudi Property Focus with $10 Billion Luxury Developments
There is no sovereign immunity for poisoning millions with drugs.
Mohammed bin Salman’s Global Standing: Strategic Partner in Transition Amid Debate Over His Role
Saudi Arabia Opens Property Market to Foreign Buyers in Landmark Reform
The U.S. State Department’s account in Persian: “President Trump is a man of action. If you didn’t know it until now, now you do—do not play games with President Trump.”
CNN’s Ranking of Israel’s Women’s Rights Sparks Debate After Misleading Global Index Comparison
Saudi Arabia’s Shifting Regional Alignment Raises Strategic Concerns in Jerusalem
OPEC+ Holds Oil Output Steady Amid Member Tensions and Market Oversupply
Iranian Protests Intensify as Another Revolutionary Guard Member Is Killed and Khamenei Blames the West
President Trump Says United States Will Administer Venezuela Until a Secure Leadership Transition
Delta Force Identified as Unit Behind U.S. Operation That Captured Venezuela’s President
Trump Announces U.S. Large-Scale Strike on Venezuela, Declares President Maduro and Wife Captured
Saudi-UAE Rift Adds Complexity to Middle East Diplomacy as Trump Signals Firm Leadership
OPEC+ to Keep Oil Output Policy Unchanged Despite Saudi-UAE Tensions Over Yemen
Saudi Arabia and UAE at Odds in Yemen Conflict as Southern Offensive Deepens Gulf Rift
Abu Dhabi ‘Capital of Capital’: How Abu Dhabi Rose as a Sovereign Wealth Power
Diamonds Are Powering a New Quantum Revolution
Trump Threatens Strikes Against Iran if Nuclear Programme Is Restarted
Why Saudi Arabia May Recalibrate Its US Spending Commitments Amid Rising China–America Rivalry
Riyadh Air’s First Boeing 787-9 Dreamliner Completes Initial Test Flight, Advancing Saudi Carrier’s Launch
Saudi Arabia’s 2025: A Pivotal Year of Global Engagement and Domestic Transformation
Saudi Arabia to Introduce Sugar-Content Based Tax on Sweetened Drinks from January 2026
Saudi Hotels Prepare for New Hospitality Roles as Alcohol Curbs Ease
Global Airports Forum Highlights Saudi Arabia’s Emergence as a Leading Aviation Powerhouse
Saudi Arabia Weighs Strategic Choice on Iran Amid Regional Turbulence
Not Only F-35s: Saudi Arabia to Gain Access to the World’s Most Sensitive Technology
Saudi Arabia Condemns Sydney Bondi Beach Shooting and Expresses Solidarity with Australia
Washington Watches Beijing–Riyadh Rapprochement as Strategic Balance Shifts
Saudi Arabia Urges Stronger Partnerships and Efficient Aid Delivery at OCHA Donor Support Meeting in Geneva
Saudi Arabia’s Vision 2030 Drives Measurable Lift in Global Reputation and Influence
Alcohol Policies Vary Widely Across Muslim-Majority Countries, With Many Permitting Consumption Under Specific Rules
Saudi Arabia Clarifies No Formal Ban on Photography at Holy Mosques for Hajj 2026
Libya and Saudi Arabia Sign Strategic MoU to Boost Telecommunications Cooperation
Elon Musk’s xAI Announces Landmark 500-Megawatt AI Data Center in Saudi Arabia
Israel Moves to Safeguard Regional Stability as F-35 Sales Debate Intensifies
Cardi B to Make Historic Saudi Arabia Debut at Soundstorm 2025 Festival
U.S. Democratic Lawmakers Raise National Security and Influence Concerns Over Paramount’s Hostile Bid for Warner Bros. Discovery
Hackers Are Hiding Malware in Open-Source Tools and IDE Extensions
Traveling to USA? Homeland Security moving toward requiring foreign travelers to share social media history
Wall Street Analysts Clash With Riyadh Over Saudi Arabia’s Deficit Outlook
Trump and Saudi Crown Prince Cement $1 Trillion-Plus Deals in High-Profile White House Summit
Saudi Arabia Opens Alcohol Sales to Wealthy Non-Muslim Residents Under New Access Rules
U.S.–Saudi Rethink Deepens — Washington Moves Ahead Without Linking Riyadh to Israel Normalisation
Saudi Arabia and Israel Deprioritise Diplomacy: Normalisation No Longer a Middle-East Priority
Saudi Arabia Positions Itself as the Backbone of the Global AI Era
As Trump Deepens Ties with Saudi Arabia, Push for Israel Normalization Takes a Back Seat
Thai Food Village Debuts at Saudi Feast Food Festival 2025 Under Thai Commerce Minister Suphajee’s Lead
Saudi Arabia Sharpens Its Strategic Vision as Economic Transformation Enters New Phase
Saudi Arabia Projects $44 Billion Budget Shortfall in 2026 as Economy Rebalances
×